Researchers at Uppsala University have identified a promising therapeutic approach for the challenging blood cancer multiple ...

MicroRNA-33a and microRNA-33b are encoded within the mammalian SREBF1 and SRBF2 genes, respectively, and both SREBF1 and ...

Immune checkpoint inhibitors (ICIs), a powerful form of immunotherapy, have revolutionized cancer treatment by unleashing the body's own immune system to fight tumors.

Researchers have found in a new research that SGLT2 inhibitors may provide dual benefits in treating both diabetes and fatty ...

Scientists uncover shared genetic signals between chronic dry cough and ACE inhibitor-induced cough, pointing to neurological ...

With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent ...

Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

SGLT2 inhibitors and GLP-1 receptor agonists lower cardiovascular risk in type 2 diabetes, but a recent review suggests that ...

Nausea and, to a lesser extent, vomiting are among the most common adverse effects associated with all the three FDA-approved PARP inhibitors (olaparib, niraparib, and rucaparib) in patients with ...

Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...